Somerset, NJ – February, 6, 2014 — The Catalent Applied Drug Delivery Institute today announced that it will hold its second European educational and training event, “Overcoming Bioavailability Challenges” at the Novartis global headquarters campus in Basel, Switzerland, on Thursday, March 27th. World-leading experts on drug development and delivery from across industry and academia will share the most effective and innovative approaches and technologies for improving drug bioavailability, including speakers from 3M, Hovione, BASF, Formac Pharmaceuticals, Agere Pharmaceuticals, Saarland University and Catalent Pharma Solutions.
The sessions will focus on innovative strategies for overcoming challenges in the delivery of poorly soluble and permeable drugs, as well as the benefits of utilizing new drug delivery technology platforms to deliver better treatments for patients. In addition to the presentations there will be a panel discussion looking at current trends in the use of advanced delivery technologies. To view the full agenda, list of participating experts, and the link for free registration visit the event page (www.drugdeliveryinstitute.com/events).
“Attendees will gain expert insights and innovative bioavailability strategies to help overcome the complex drug delivery challenges they face, as well as an understanding of the value of closer collaboration between industry & academia,” commented Terry Robinson, Executive Director, Catalent Institute. “This second European event follows the inaugural October event at the Royal Society of Chemistry in London, which had strong participation from European pharmaceutical developers and academia.”
Established in 2012, the Institute adopts a multi-tiered approach to accelerate the adoption of advanced drug delivery technologies through industry and academic collaboration, research, education, and the sharing of information.
For more details, visit www.drugdeliveryinstitute.com.
About Catalent Applied Drug Delivery Institute
Catalent’s Applied Drug Delivery Institute was founded to serve as a link between industry and academia, advance education and training in drug delivery in academia and the industry, accelerate adoption of applied drug delivery technologies to develop better treatments and foster industry collaboration on major issues pertaining to drug development, formulation and delivery. It is pursuing a multi-tiered approach of research, strategic counsel, and educational programs to advance the adoption of emerging technologies.
Catalent Pharma Solutions is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 75 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,500 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and in Fiscal 2013 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit www.catalent.com.
More products. Better treatments. Reliably supplied.™